ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,873 | +2.9% | 112,467 | +15.5% | 0.00% | 0.0% |
Q2 2023 | $2,792 | +34.8% | 97,355 | +12.6% | 0.00% | +100.0% |
Q1 2023 | $2,071 | +12.6% | 86,433 | -20.3% | 0.00% | 0.0% |
Q4 2022 | $1,839 | -99.9% | 108,496 | -10.1% | 0.00% | -50.0% |
Q3 2022 | $1,790,000 | +155.0% | 120,743 | +170.5% | 0.00% | – |
Q2 2022 | $702,000 | +631.2% | 44,637 | +1146.8% | 0.00% | – |
Q1 2022 | $96,000 | -94.9% | 3,580 | -93.0% | 0.00% | – |
Q4 2021 | $1,898,000 | +248.9% | 51,246 | +349.6% | 0.00% | – |
Q3 2021 | $544,000 | +365.0% | 11,397 | +231.6% | 0.00% | – |
Q2 2021 | $117,000 | -91.7% | 3,437 | -89.9% | 0.00% | -100.0% |
Q1 2021 | $1,409,000 | -57.1% | 34,131 | -55.0% | 0.00% | -50.0% |
Q4 2020 | $3,288,000 | +786.3% | 75,806 | +775.0% | 0.00% | – |
Q3 2020 | $371,000 | -74.9% | 8,664 | -72.6% | 0.00% | -100.0% |
Q2 2020 | $1,477,000 | +4002.8% | 31,638 | +1083.2% | 0.00% | – |
Q1 2020 | $36,000 | +800.0% | 2,674 | +664.0% | 0.00% | – |
Q4 2019 | $4,000 | +300.0% | 350 | +386.1% | 0.00% | – |
Q3 2019 | $1,000 | – | 72 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |